Status:

RECRUITING

Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model

Lead Sponsor:

Inotrem

Collaborating Sponsors:

IRCCS San Raffaele

Conditions:

Inflammatory Bowel Diseases

Eligibility:

All Genders

18-60 years

Brief Summary

TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease. The main objective of the study is to confirm the t...

Eligibility Criteria

Inclusion

  • Patients between 18 and 60 years
  • Signed informed consent
  • Ulcerative colitis (UC) patients with active disease
  • Crohn's disease (CD) patients with active disease

Exclusion

  • UC or CD patients in remission
  • Patients between 18 and 60 years without informed consent

Key Trial Info

Start Date :

January 31 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06580418

Start Date

January 31 2023

End Date

March 31 2025

Last Update

February 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS San Raffaele

Milan, Italy

Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model | DecenTrialz